share_log

【持股变动报告】股东报告减持OncoTherapy Science(4564.JP)股份至8.46%

Insider decrases its stake in OncoTherapy Science(4564.JP) to 8.46%

Futu News ·  Jul 1 14:01

On Jul 1, Long Corridor Asset Management Limited submitted the Change Report to Ministry of Finance. The report shows that Long Corridor Asset Management Limited decreased their holdings in $OncoTherapy Science (4564.JP)$, with their joint shareholding ratio down from 9.87% to 8.46%.

JPStockInsiderTradingAutoNewsSpider_nn_S100TYHZ_1719813660_en-us

Source: Edinet Announcement

What is the 5% shareholding reporting system?

Shareholders with holding ratio exceeding 5% must submit a Large Shareholding Report within five business days from that day. If the holding ratio increases or decreases by 1% or more after submitting a Large Shareholding Report, the holder must submit a Change Report within five business days from that day.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment